Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Crohn Disease × vedolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 1 Crohn Disease 1 Colitis, Ulcerative 1

Interventions

vedolizumab 1 secukinumab 1 Vitamin E 1 Nivolumab 1 MEDI2070 1 Iron-Dextran Complex 1 Infliximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02768532 2023-06-15

VEDO-PREDIRESP

Centre Hospitalier Universitaire de Saint Etienne

Phase 4 Terminated

Crohn Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡